Concepedia

Jos G. W. Kosterink

JG

100

Publications

5.7K

Citations

40

H-Index

1989

Active since

Affiliations

University Medical Center Groningen(Current)

University of Groningen

Radboud University Nijmegen

Radboud University Medical Center

National Institute for Public Health and the Environment

Jos G. W. Kosterink is an author at University Medical Center Groningen specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1989–2023

100

Publications

100

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

Eli Dijkers, Thijs H. Oude Munnink, Jos G. W. Kosterink et al. · Clinical Pharmacology & Therapeutics · 2010 · 792 citations

Development and Characterization of Clinical-Grade <sup>89</sup>Zr-Trastuzumab for HER2/<i>neu</i> ImmunoPET Imaging

Eli Dijkers, Jos G. W. Kosterink, Anna P. Rademaker et al. · Journal of Nuclear Medicine · 2009 · 334 citations · Full text

Indium-111–Labeled Trastuzumab Scintigraphy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Patrick J. Perik, Marjolijn N. Lub–de Hooge, Jourik A. Gietema et al. · Journal of Clinical Oncology · 2006 · 307 citations · Full text

Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies

Anton G.T. Terwisscha van Scheltinga, Gooitzen M. van Dam, Wouter B. Nagengast et al. · Journal of Nuclear Medicine · 2011 · 196 citations · Full text

Preclinical characterisation of <sup>111</sup>In‐DTPA‐trastuzumab

Marjolijn N. Lub‐de Hooge, Jos G. W. Kosterink, Patrick J. Perik et al. · British Journal of Pharmacology · 2004 · 176 citations · Full text

Rows per page

1–5 of 100